Lymphoma

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Featured

Video
Villarraga
Video
Anthracycline Associated With Heart Failure in Patients Treated for Breast Cancer, Lymphoma
08/13/2024
In this video, Hector R. Villarraga, MD, discusses the long-term incidence of heart failure in patients with breast cancer or lymphoma treated with anthracycline therapy and the clinical impact of his...
08/13/2024
FDA Alert
FDA Alert
FDA Alert
FDA Grants Accelerated Approval for First CAR-T Cell Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
04/22/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA previously approved lisocabtagene maraleucel as a second-line treatment option for adult patients with large B-cell lymphoma in June 2022.
04/22/2024
Video
Diana Abbott
Video
Treatment Outcomes in Elderly Patients Receiving First Line Therapy for Diffuse Large B-Cell Lymphoma
04/08/2024

Diana Abbott, PhD • Grace Bosma, MS

Diana Abbott, PhD • Grace Bosma,...
In this video, Diana Abbott, PhD, and Grace Bosma, MS, discuss their team’s study on the outcomes and intensity of first-line therapy for the treatment of diffuse large B-cell lymphoma (DLBCL) in elderly...
04/08/2024

Clinical Insights

Video
Villarraga
Video
Anthracycline Associated With Heart Failure in Patients Treated for Breast Cancer, Lymphoma
08/13/2024
In this video, Hector R. Villarraga, MD, discusses the long-term incidence of heart failure in patients with breast cancer or lymphoma treated with anthracycline therapy and the clinical impact of his...
08/13/2024
Video
Diana Abbott
Video
Treatment Outcomes in Elderly Patients Receiving First Line Therapy for Diffuse Large B-Cell Lymphoma
04/08/2024

Diana Abbott, PhD • Grace Bosma, MS

Diana Abbott, PhD • Grace Bosma,...
In this video, Diana Abbott, PhD, and Grace Bosma, MS, discuss their team’s study on the outcomes and intensity of first-line therapy for the treatment of diffuse large B-cell lymphoma (DLBCL) in elderly...
04/08/2024
Conference Coverage
Mark Roschewski
Conference Coverage
Assessing End-Of-Treatment Response for Aggressive B-Cell Lymphoma After Frontline Therapy
02/20/2024

Mark Roschewski, MD

Mark Roschewski, MD
In this video, Mark Roschewski, MD, discusses the results of his team’s study of the use of PET/CT scans to assess remission status in patients with aggressive B-cell lymphoma. Dr Roschewski presented these...
02/20/2024
Conference Coverage
Mark Roschewski
Conference Coverage
Optimizing Circulating Tumor DNA Limits of Detection for Patients With Diffuse Large B-Cell Lymphoma During First Line Therapy
01/22/2024
Mark Roschewski, MD
Mark Roschewski, MD
In this video, Mark Roschewski, MD, discusses the key points from his team’s research that investigated the value of circulating tumor DNA when treating patients with diffuse large B-cell lymphoma. The...
01/22/2024
Video
Paolo Strati, MD
Video
Novel Combinations in Indolent Lymphoma
09/27/2023

Paolo Strati, MD

Paolo Strati, MD
In this video, Paolo Strati, MD, discusses chemotherapy-free approaches in the treatment of patients with indolent b-cell lymphoma, including early trials that are underway on the combination of...
09/27/2023